Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 8.83654 | 96 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 8.99035 | 96 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 8.82184 | 96 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 8.55909 | 95 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 8.72674 | 96 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 8.67444 | 96 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 7.8596 | 94 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 8.2395 | 94 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 8.33695 | 95 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 8.65618 | 95 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 8.52837 | 95 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 8.7415 | 96 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 8.6067 | 95 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 8.72214 | 96 |